Sensitivity and Specificity of the Roth Test in Patients With COVID-19 Positive
Study Details
Study Description
Brief Summary
The presence of the described silent hypoxia in subjects diagnosed with COVID19 highlights the need for valid tools to assess respiratory capacity. The Roth test has been associated with acceptable sensitivity and specificity criteria in patients with previous respiratory pathology; however, its validity in this type of patient has not been proven.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| COVID+ Group Patients diagnosed with Covid19 positive in last 7 days |
Diagnostic Test: Roth´s Test
Subjets must count from 1 to 30 in their languages, and health professional will count seconds that last in take breath during the count.
|
Outcome Measures
Primary Outcome Measures
- Oxygen Saturation [12 weeks]
The pulseoximeter percentage value
Secondary Outcome Measures
- Roth´s test [12 weeks]
The level described in the test
Eligibility Criteria
Criteria
Inclusion Criteria:
-
having been diagnosed as COVID-19 positive and with symptoms compatible with Sars-Cov-2 infection in the last 7 days prior to assessment,
-
having an understanding of Spanish,
-
and having no history of respiratory pathology prior to the current infection.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | CS Entrevías | Madrid | Spain | 28053 |
Sponsors and Collaborators
- Universidad Autonoma de Madrid
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- PI-4321